The global chronic disease management market addresses the growing global burden of conditions such as diabetes, cardiovascular diseases, respiratory disorders, and cancer. These pose challenges to healthcare systems worldwide. Rising incidence rates drive demand for disease management services, aiding medication adherence and direct patient care. As cases increase, the market is expected to grow, emphasizing the need for effective solutions in the forecast period.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/global-chronic-disease-management-market
Data Bridge Market Research analyzes that the Global Chronic Disease Management Market which was USD 6.17 billion in 2022, would reach up to USD 20.64 billion by 2030, and is expected to undergo a CAGR of 16.3% during the forecast period of 2023-2030. The elderly, aged 65 and above, often experience a higher prevalence of diseases due to diminished quality of life, weakened immune systems, and reduced self-efficacy. Dementia is particularly prevalent in this group. The rising senior population fuels the demand for chronic disease management, driving growth in the market.
Key Findings of the Study
The surge in disease management programs is expected to drive the market's growth rate
Disease management programs, incorporating coordinated interventions and self-management strategies, are gaining popularity globally due to the increasing prevalence of chronic diseases. Government and healthcare organizations implement programs such as diabetes care and asthma management to enhance self-care, reduce hospital visits, and improve outcomes. As these programs demonstrate the potential to significantly enhance healthcare efficiency, the growing interest in disease management programs is anticipated to present substantial opportunities for the global chronic disease management market in the foreseeable future.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2022 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Solution and Services), Solution Type (On-Premise Solution, Cloud-Based Solution, and Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service, and Others), Disease Indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer, and Others), End User (Healthcare Providers, Healthcare Payers, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America
|
|
Market Players Covered
|
WellSky (U.S.), ZeOmega (India), Health Catalyst (U.S.), Cedar Gate Technologies (U.S.), Cognizant (U.S.), Pegasystems Inc. (U.S.), Epic Systems Corporation (U.S.), Hinduja Global Solutions Ltd. (India), NXGN Management, LLC (U.S.), MINES & Associates, Inc. (U.S.), Casenet, LLC (U.S.), ExlServings Holdings, Inc. (U.S.), cliexa, Inc. (U.S.), ScienceSoft USA Corporation (U.S.), Vivify Health, Inc. (U.S.), Allscripts Healthcare, LLC (U.S.), Infosys Limited (India), Medecision (U.S.), IBM (U.S.), Altruista Health (U.S.), and TCS Healthcare Technologies (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global chronic disease management market is categorized into five notable segments based on type, solution type, service type, disease type and end user.
- On the basis of type, the global chronic disease management market is segmented into solution and services. The solution segment is expected to dominate the chronic disease management with 58.43% market share due to rising technological advancements in chronic disease management solutions
The solution segment is expected to dominate the global chronic disease management market
The solution segment is expected to dominate the chronic disease management market with 58.43% market share due to rising technological advancements in chronic disease management solutions
- On the basis of solution type, the global chronic disease management market is segmented into on-premise solution, cloud-based solution, web-based. The on-premise solution vectors segment is expected to dominate the chronic disease management market with a 42.29% market share due to the rising adoption of enterprise application software and enhanced internal processing support
- On the basis of service type, the global chronic disease management market is segmented into educational service, implementation service, consulting service and others. The implementation services segment is expected to dominate the chronic disease management market with a 46.05% market share due to rising research and development activities in various developing countries
The implementation services segment is expected to dominate the global chronic disease management market
The implementation services segment is expected to dominate the chronic disease management market with a 46.05% market share due to rising research and development activities in various developing countries
- On the basis of disease type, the global chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer, and others. The cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market growing with 35.36% market share due to the rising prevalence and incidence of cardiovascular diseases (CVD) across the globe
- On the basis of end user, the global chronic disease management market is segmented into healthcare providers, healthcare payers, others. The healthcare providers segment is expected to dominate the chronic disease management market with a 53.53% market share due to rise in a number of hospitals and advanced Healthcare providers in low and middle-income countries
Major Players
Data Bridge Market Research recognizes the following companies as the major global chronic disease management market players in global chronic disease management market are WellSky (U.S.), ZeOmega (India), Health Catalyst (U.S.), Cedar Gate Technologies (U.S.), Cognizant (U.S.), Pegasystems Inc. (U.S.), Epic Systems Corporation (U.S.), Hinduja Global Solutions Ltd. (India), NXGN Management, LLC (U.S.)
Market Developments
- In April 2021, WellSky launched an advanced home health visit management solution. The new addition CareInsights Guidance provides actionable visit utilization insights to balance care quality and patient health improvement. It is predicted that this solution launch will provide benefits to their patients, staff, and leading to an upsurge in the company's sales growth
- In 2020, Ochsner Health System took the initiative by merging their technological advancements with Apple to tackle chronic disease management. This new system of care significantly reduced time and costs, thereby improved patient outcomes.
- In December 2020, HGS AxisPoint Health, partnered with Parkland Community Health Plan (PCHP). The primary purpose of this partnership was to supply disease management services to approximately 195,000 Medicaid beneficiaries in North Texas. This enhanced the company’s presence in the global market, leading to an upsurge in the company's sales growth
Regional Analysis
Geographically, the countries covered in the global chronic disease management market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in global chronic disease management market during the forecast period 2023-2030
North America dominates the global chronic disease management market, driven by a rising geriatric population and advancements in technology. The region benefits from the substantial presence of major market players, contributing to a flourishing growth rate. The convergence of these factors positions North America at the forefront of innovative solutions for chronic disease management, with an emphasis on addressing the healthcare needs of an aging population through cutting-edge technologies and comprehensive healthcare strategies.
Asia-Pacific is estimated to be the fastest growing region in global chronic disease management market the forecast period 2023-2030
Asia-Pacific is expected to dominate the global chronic disease management market from 2023 to 2030, fueled by the expanding availability of providers. The region's rising access to chronic disease management services contributes to improved healthcare infrastructure. With increasing awareness and adoption of these services, Asia-Pacific is poised for significant growth, meeting the escalating demand for effective solutions in managing chronic diseases across diverse populations during the forecast period.
For more detailed information about the global chronic disease management market report, click here – https://www.databridgemarketresearch.com/es/reports/global-chronic-disease-management-market
